X |
Filing Date |
Trade Date |
Ticker |
Company Name | Industry | Ins |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5 | 2025-12-12 | BCIC | Bcp Investment Corp | Closed-End Funds | 5 | P - Purchase | $13.63 | +97,943 | 127,302 | +334% | +$1,334,963 | |||||
| 3 M | 2025-12-12 | SPMC | Sound Point Meridian Capital, Inc. | Closed-End Funds | 2 | P - Purchase | $15.32 | +31,162 | 177,646 | +21% | +$477,322 | |||||
| 3 | 2025-12-16 | COO | Cooper Companies, Inc. | Ophthalmic Goods | 3 | P - Purchase | $78.92 | +13,230 | 280,980 | +5% | +$1,044,103 | |||||
| 3 M | 2025-12-12 | GOGO | Gogo Inc. | Communications Services | 2 | P - Purchase | $6.25 | +370,000 | 32,518,625 | +1% | +$2,313,499 | |||||
| 4 | 2025-12-11 | ELAN | Elanco Animal Health Inc | Pharmaceutical Preparations | 4 | P - Purchase | $21.59 | +43,450 | 2,348,468 | +2% | +$937,907 | |||||
| 2 | 2025-11-11 | MSDL | Morgan Stanley Direct Lending Fund | Closed-End Funds | 2 | P - Purchase | $16.66 | +12,030 | 53,042 | +29% | +$200,389 | |||||
| 7 M | 2025-12-15 | CFND | C1 Fund Inc. | Closed-End Funds | 2 | P - Purchase | $5.23 | +67,630 | 335,237 | +25% | +$353,908 | |||||
| 24 M | 2025-12-12 | TPVG | Triplepoint Venture Growth Bdc Corp. | Closed-End Funds | 2 | P - Purchase | $6.33 | +1,765,598 | 3,486,393 | +103% | +$11,184,064 | |||||
| 2 D | 2025-12-15 | RLMD | Relmada Therapeutics, Inc. | Pharmaceutical Preparations | 2 | P - Purchase | $4.12 | +39,165 | 2,100,000 | +2% | +$161,360 | |||||
| 2 M | 2025-12-11 | SI | Shoulder Innovations, Inc. | Surgical & Medical Instruments & Apparatus | 2 | P - Purchase | $14.85 | +9,200 | 172,952 | +6% | +$136,641 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-12-12 | BCIC | Bcp Investment Corp | Schafer Patrick | Chief Investment Officer | P - Purchase | $13.63 | +11,005 | 24,610 | +81% | +$149,998 | ||||||
2025-12-12 | BCIC | Bcp Investment Corp | Satoren Brandon | CFO, Treasurer, Secretary | P - Purchase | $13.63 | +2,567 | 4,686 | +121% | +$34,988 | ||||||
2025-12-12 | BCIC | Bcp Investment Corp | Goldthorpe Edward J. | Pres, CEO | P - Purchase | $13.63 | +73,367 | 86,140 | +574% | +$999,992 | ||||||
| M | 2025-12-11 | NYC | American Strategic Investment Co. | Schorsch Nicholas S | 10% | P - Purchase | $8.02 | +4,180 | 1,588,119 | 0% | +$33,541 | |||||
| M | 2025-12-12 | SPMC | Sound Point Meridian Capital, Inc. | Desai Ujjaval | CEO | P - Purchase | $13.62 | +3,162 | 81,741 | +4% | +$43,052 | |||||
| M | 2025-12-12 | BH | Biglari Holdings Inc. | Biglari, Sardar | COB, CEO, 10% | P - Purchase | $669.69 | +817 | 1,558,592 | 0% | +$547,138 | |||||
| M | 2025-12-12 | HYMC | Hycroft Mining Holding Corp | Sprott Eric | 10% | P - Purchase | $13.05 | +440,000 | 30,386,352 | +1% | +$5,742,000 | |||||
| AM | 2025-12-09 | AMR | Alpha Metallurgical Resources, Inc. | Courtis Kenneth S. | Dir | P - Purchase | $180.92 | +37,000 | 807,537 | +5% | +$6,694,203 | |||||
2025-12-12 | IPSC | Century Therapeutics, Inc. | Pfeiffenberger Brent | Pres, CEO | P - Purchase | $0.58 | +52,000 | 3,322,990 | +2% | +$30,352 | ||||||
2025-12-16 | COO | Cooper Companies, Inc. | Sheffield Holly R | Pres, CSI | P - Purchase | $80.75 | +1,230 | 39,052 | +3% | +$99,323 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-12-12 | IPSC | Century Therapeutics, Inc. | Pfeiffenberger Brent | Pres, CEO | P - Purchase | $0.58 | +52,000 | 3,322,990 | +2% | +$30,352 | ||||||
2025-12-16 | KLXE | Klx Energy Services Holdings, Inc. | Bouthillette Max | See Remarks | P - Purchase | $1.67 | +16,500 | 142,865 | +13% | +$27,555 | ||||||
2025-12-15 | DHC | Diversified Healthcare Trust | Bilotto Christopher J. | Pres, CEO | P - Purchase | $4.89 | +20,000 | 266,285 | +8% | +$97,720 | ||||||
| M | 2025-12-12 | GPUS | Hyperscale Data, Inc. | Ault Milton C III | Exec COB, 10% | P - Purchase | $0.26 | +140,100 | 650,671 | +27% | +$36,148 | |||||
| M | 2025-12-15 | SMRT | Smartrent, Inc. | Martell Frank | CEO | P - Purchase | $2.06 | +50,000 | 2,113,796 | +2% | +$103,244 | |||||
2025-12-15 | CFND | C1 Fund Inc. | Kidwai Najamul Hasan | CEO | P - Purchase | $4.93 | +12,030 | 237,737 | +5% | +$59,308 | ||||||
2025-12-15 | COSM | Cosmos Health Inc. | Siokas Grigorios | CEO, 10% | P - Purchase | $0.42 | +168,472 | 6,628,457 | +3% | +$70,000 | ||||||
| D | 2025-12-15 | RLMD | Relmada Therapeutics, Inc. | Traversa Sergio | CEO | P - Purchase | $4.12 | +27,500 | 1,300,000 | +2% | +$113,300 | |||||
| D | 2025-12-15 | RLMD | Relmada Therapeutics, Inc. | Shenouda Maged | CFO | P - Purchase | $4.12 | +11,665 | 800,000 | +1% | +$48,060 | |||||
2025-12-15 | ASST | Strive, Inc. | Cole Matthew Ryan | CEO | P - Purchase | $0.81 | +515,195 | 700,380 | +278% | +$415,999 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-12-12 | IRON | Disc Medicine, Inc. | Bitterman Kevin | Dir | S - Sale+OE | $91.56 | -184,123 | 14,161 | -93% | -$16,858,639 | |||||
2025-12-15 | IRON | Disc Medicine, Inc. | Savage William Jacob | Chief Medical Officer | S - Sale | $91.22 | -13,093 | 75,702 | -15% | -$1,194,372 | ||||||
| M | 2025-12-15 | TONX | Ton Strategy Co | Cutaia Rory J. | Dir | S - Sale | $2.57 | -88,626 | 12,506 | -88% | -$227,569 | |||||
| M | 2025-12-15 | RKLB | Rocket Lab Corp | Beck Peter | CEO | S - Sale | $56.44 | -2,500,000 | 902,942 | -73% | -$141,105,496 | |||||
| D | 2025-12-12 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale+OE | $230.76 | -4,692 | 126,450 | -4% | -$1,082,714 | |||||
2025-12-12 | NTRA | Natera, Inc. | Rosenman Herm | Dir | S - Sale | $227.42 | -48,419 | 20,342 | -70% | -$11,011,477 | ||||||
| M | 2025-12-12 | AL | Air Lease Corp | Udvar-Hazy Steven F | Dir | S - Sale | $64.08 | -149,632 | 2,297,792 | -6% | -$9,588,527 | |||||
| D | 2025-12-15 | ADMA | Adma Biologics, Inc. | Grossman Adam S | Pres, CEO | S - Sale+OE | $19.79 | -21,000 | 3,732,233 | -1% | -$415,590 | |||||
| M | 2025-12-12 | AL | Air Lease Corp | Korde Kishore | EVP | S - Sale | $64.10 | -29,172 | 51,145 | -36% | -$1,869,925 | |||||
2025-12-16 | WTM | White Mountains Insurance Group Ltd | Gelston Philip A | Dir | S - Sale | $2,048.51 | -165 | 1,568 | -10% | -$338,004 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-12 | KBONU | Karbon Capital Partners Corp. | Karam Thomas F | CEO, 10% | A - Grant | $10.00 | +890,000 | 890,000 | New | +$8,900,000 | |||||
| D | 2025-12-12 | KBONU | Karbon Capital Partners Corp. | Karbon Capital Partners Core Holdings, LLC | Dir, 10% | A - Grant | $10.00 | +890,000 | 890,000 | New | +$8,900,000 | |||||
| D | 2025-12-12 | KBONU | Karbon Capital Partners Corp. | Zajkowski Jeffrey J. | CFO, 10% | A - Grant | $10.00 | +890,000 | 890,000 | New | +$8,900,000 | |||||
2025-12-15 | ALE | Allete Inc | Skelton Joshua Jon | VP; COO-Minnesota Power | D - Sale to issuer | $55.62 | -19,255 | 0 | -100% | -$1,070,987 | ||||||
2025-12-15 | ALE | Allete Inc | Scissons Jeffrey John | VP CFO, Corp Treasurer | D - Sale to issuer | $37.60 | -5,844 | 0 | -100% | -$219,751 | ||||||
2025-12-15 | ALE | Allete Inc | Padilla Julie L | VP, Ch Legal Offcr, Secretary | D - Sale to issuer | $6.11 | -2,307 | 0 | -100% | -$14,083 | ||||||
2025-12-15 | ALE | Allete Inc | Johnson Nicole Renee | VP; Pres- ACE | D - Sale to issuer | $50.06 | -17,656 | 0 | -100% | -$883,836 | ||||||
2025-12-15 | ALE | Allete Inc | Anderson Colin B | VP-ALLETE Chf Acct Offr, Cont | D - Sale to issuer | $22.87 | -2,549 | 0 | -100% | -$58,299 | ||||||
2025-12-15 | ALE | Allete Inc | Owen Bethany M | Chair, Pres, CEO | D - Sale to issuer | $44.39 | -52,064 | 0 | -100% | -$2,311,109 | ||||||
2025-12-15 | ALE | Allete Inc | Thomas Charlene A | Dir | D - Sale to issuer | $67.00 | -8,311 | 0 | -100% | -$556,812 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |